Journal articles: 'Hepatic Echinococcosis'

1

Lorenz, Andreas, and Christian Andreas Nebiker. "Hepatic Echinococcosis." Journal of Gastrointestinal Surgery 21, no. 8 (January 17, 2017): 1361–62. http://dx.doi.org/10.1007/s11605-017-3367-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Akin, O., and I. Isiklar. "Hepatic Alveolar Echinococcosis." Acta Radiologica 40, no. 3 (May 1999): 326–28. http://dx.doi.org/10.3109/02841859909175562.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Goncharov, A. B., Y. A. Kovalenko, Kh A. Ayvazyan, R. Z. Ikramov, L. A. Marinova, V. A. Vishnevsky, and A. V. Chzhao. "“Complex” hepatic echinococcosis." Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 26, no. 4 (October 27, 2021): 32–40. http://dx.doi.org/10.16931/1995-5464.2021-4-32-40.

Full text

Abstract:

Aim. To study the long-term results of surgical treatment in patients with “complex” hepatic echinococcosis.Materials and methods. The results of surgical treatment of 118 patients with hepatic echinococcosis from 2015 to 2020 at the A.V. Vishnevsky National Medical Research Center of Surgery were analyzed. The term “complex” hepatic echinococcosis has been proposed. A comparative analysis of the number and type of complications and surgical interferences 2 groups of patients was carried out: 66 patients with hepatic echinococcosis, 52 patients with complex hepatic echinococcosis.Results. During the observation period, no any recurrence was recorded. 55 (44%) of 118 patients had complex hepatic echinococcosis. Isolated liver damage was found in 74% of cases, combined liver and lung damage in 20% cases and with other organs – in 6%. In most cases, pericystectomy was performed (82%), 8% of patients underwent atypical hepatectomy, 4% – segmental resection, 3% – laparoscopic intervention, 3% – hemihepatectomy. Postoperative complications were recorded in 22 (18,6%) of cases. Accumulations of bile and biliary fistulas formed in 45% of cases, pneumotothorax or hydrothorax – in 23%, wound abscess – in 18%, hematomas in the hepatectomy zone – in 14% of the cases.Conclusion. Surgical treatment of complex hepatic echinococcosis requires an individual approach to the choice of the operation option. Preference should be given to parenchyma-preserving radical operations. When the liver lobe is totally replaced with a hydatid cyst and in case of cystobiliary fistulas hemihepatectomy should be performed, and it is acceptable to leave the fibrous capsule on large tubular structures.

APA, Harvard, Vancouver, ISO, and other styles

4

Bresson-Hadni, Solange, Laurent Spahr, and François Chappuis. "Hepatic Alveolar Echinococcosis." Seminars in Liver Disease 41, no. 03 (June 23, 2021): 393–408. http://dx.doi.org/10.1055/s-0041-1730925.

Full text

Abstract:

AbstractHepatic alveolar echinococcosis (HAE) is a rare but severe zoonosis caused by the pseudotumoral intrahepatic development of the larval stage of the tapeworm Echinococcus multilocularis. HAE is present only in the Northern Hemisphere, predominantly in China. Currently, there is a significant resurgence of cases in historically endemic areas associated with emergence of HAE in countries not previously concerned. Today, in European countries, HAE is often discovered by chance; however, clinicians should be made aware of opportunistic infections that progressively emerged recently as a result of therapeutic or pathological immunosuppression. Ultrasonography is the key first-line diagnostic procedure, with specific serology providing confirmation in 95% of the cases. Albendazole, only parasitostatic, is the mainstay for treatment. Surgical resection, if feasible, is the gold standard for treatment, and more patients are currently eligible for this option because of an earlier diagnosis. The prognosis has considerably improved but remains poor in countries where access to care is less favorable.

APA, Harvard, Vancouver, ISO, and other styles

5

Lloyd, Jentry, Lawrence Koep, Edwin Yu, and Lauritz Jensen. "Hepatic Cystic Echinococcosis." Journal of the American Osteopathic Association 114, no. 06 (June 2014): 505. http://dx.doi.org/10.7556/jaoa.2014.069.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Detry, Olivier, Nicolas Meurisse, Jean Delwaide, Jean-Baptiste Giot, Philippe Leonard, Bertrand Losson, Marie-Pierre Hayette, Noella Bletard, Paul Meunier, and Pierre Honoré. "Hepatic alveolar echinococcosis." Acta Chirurgica Belgica 118, no. 6 (April 13, 2018): 402–3. http://dx.doi.org/10.1080/00015458.2018.1427838.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Sweetser, Seth, and Conor G. Loftus. "Massive hepatic echinococcosis." Hepatology 53, no. 5 (April 22, 2011): 1771–72. http://dx.doi.org/10.1002/hep.24139.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Xu, Xiaolei, Cancan Gao, Haiwen Ye, Zhixin Wang, Zhan Wang, Ying Zhou, Haijiu Wang, et al. "Diagnosis and treatment of a case of hepatic mixed echinococcosis infection combined with distant organ metastasis." Journal of International Medical Research 48, no. 2 (June 2, 2019): 030006051985165. http://dx.doi.org/10.1177/0300060519851651.

Full text

Abstract:

Hydatidosis is a zoonotic parasitic disease caused by Echinococcus, which is highly prevalent in pastoral areas. In China, this disease is mainly caused by Echinococcus granulosus and Echinococcus multilocularis. Cystic echinococcosis, which is one of the most common types of echinococcosis, is described as swelling and growth of cystic lesions. Alveolar echinococcosis, which is less common, is invasive. Cases of mixed echinococcosis infection accompanied by extrahepatic organ metastasis are extremely rare. Treatment of these cases is complicated and the prognosis is extremely poor. We report a case of hepatic echinococcosis in a 40-year-old Tibetan man who was treated with the hepatic right tricuspidectomy + left hepatic duct jejunostomy (Roux-en-Y) surgical procedure. This procedure provides a reference for treatment of similar cases of echinococcosis. For patients with multiorgan metastasis, chemotherapy is the first choice. This should be followed by possible surgical treatment for life-threatening lesions of alveolar echinococcosis and subsequent chemotherapy. Individualized treatment accompanied by multidisciplinary treatment and damage control surgery could optimally benefit patients with advanced hepatic echinococcosis.

APA, Harvard, Vancouver, ISO, and other styles

9

Bhutani, Namita, and Pradeep Kajal. "Hepatic echinococcosis: A review." Annals of Medicine and Surgery 36 (December 2018): 99–105. http://dx.doi.org/10.1016/j.amsu.2018.10.032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Voskanyan, S. E., E. V. Naidenov, A. N. Bashkov, and S. V. Cholakyan. "Optimization of surgical tactics in hepatic echinococcosis." Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 26, no. 4 (October 29, 2021): 41–50. http://dx.doi.org/10.16931/1995-5464.2021-4-41-50.

Full text

Abstract:

Aim. Optimization of the surgical tactics in hepatic echinococcosis.Material and methods. From 2009 to 2021, 56 patients with hepatic echinococcosis have been operated: 6 patients underwent PAIR, 7 – open echinococcectomy, 18 – pericystectomy (“ideal echinococcectomy”) and 16 – anatomical hepatectomy (S2/3, S6/7 bisegmentectomy) or atypical resection. In 7 cases hemigepatectomy has been performed, in 2 – combined interventions have been performed for echinococcosis relapse of the abdominal cavity.Results. The duration of minor hepatic resection was shorter than pericystectomy and major hepatic resection. The smallest blood loss was noted in patients who underwent open echinococcectomy, anatomical and atypical hepatectomy. No complications after PAIR were noticed. The lowest incidence of postoperative complications, including biliary complications, was found after hepatic resection interventions. The lenths of hospital stay after hepatic resections was significantly shorter compared to ecinococcectomy and pericystectomy. The reccurence of hepatic echinococcosis relapse was detected in 4 (66.7%) patients after PAIR and 2 (28.6%) patients after ecinococcectomy.Conclusion. Organ-preserving techniques should be a priority in the surgical treatment of hepatic echinococcosis. The best results in terms of the early postoperative complications frequency in the hepatic echinococcosis treatment were demonstrated by minor hepatic resections. Open echinococcectomy should be performed only for central location of large cysts and (or) their massive contact with the liver vessels. Minimally invasive resection technologies demonstrate optimal short- and long-term results. Major hepatectomy should be performed very selectively and only in those cases when they have advantages over other methods, and their implementation does not lead to a loss of more than 20% of healthy hepatic parenchyma. The best long-term results showed pericystectomy and hepatectomy in comparison with echinococcectomy.

APA, Harvard, Vancouver, ISO, and other styles

11

Gorbunova, M. L., S. N. Volkova, G. V. Shestakova, and E. L. Spiridonova. "A clinical case of pulmonary and hepatic echinococcosis." Kazan medical journal 98, no. 2 (April 15, 2017): 261–66. http://dx.doi.org/10.17750/kmj2017-261.

Full text

Abstract:

The article presents а description of our personal case of pulmonary and hepatic echinococcosis in a 38-years-old patient. Literature data on clinical presentation, laboratory and instrumental diagnostic methods of the disease are presented. Different variants of clinical presentation of pulmonary echinococcosis and its possible complications are described. The problems of differential diagnosis, surgical and conventional methods of treatment are analyzed. The presented clinical case confirms the wide spread opinion that the diagnosis of pulmonary echinococcosis based on only the results of chest X-ray is extremely challenging. Frequent diagnostic mistakes are associated with the primary diagnosis of pneumonia based on chest X-ray. Use of high-pitch spiral computed tomography implemented recently into clinical practice provides early differential diagnosis of pulmonary lesions with parasitic diseases, in particular, with echinococcosis. The final diagnosis is confirmed by serologic methods of echinococcosis diagnosis with the use of enzyme immunoassays.

APA, Harvard, Vancouver, ISO, and other styles

12

Balci, N. Cem, Atadan Tunaci, Richard C. Semelka, Mehtap Tunaci, Ilgin Özden, Izzet Rozanes, and Bülent Acunas. "Hepatic alveolar echinococcosis: MRI findings." Magnetic Resonance Imaging 18, no. 5 (June 2000): 537–41. http://dx.doi.org/10.1016/s0730-725x(00)00145-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Menteş, A., S. Yalaz, R. Killi, and N. Altintaş. "Radical treatment for hepatic echinococcosis." HPB 2, no. 1 (2000): 49–54. http://dx.doi.org/10.1016/s1365-182x(17)30701-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Manea, Laura-Maria, Alexandra Jichitu, Vlad Pînzariu, Nicoleta Mihaela Sprîncenatu Irina Iuliana, Mariana Anton, Adrian Bordea, and Iulia Sălcianu. "A Misleading Case of Hepatic Echinococcosis." Internal Medicine 17, no. 4 (June 1, 2020): 87–93. http://dx.doi.org/10.2478/inmed-2020-0128.

Full text

Abstract:

AbstractHydatid disease is a zoonotic disease endemic in Eastern Europe, being highly prevalent in Romania. There are some links between echinococcosis and cancer, but the true nature of the relationship between these diseases remains to be established. We present the case of a 49-year-old male with hepatic echinococcosis and concomitant hepatic metastases of a previously undiagnosed pancreatic cancer.

APA, Harvard, Vancouver, ISO, and other styles

15

Zhang, Ran, Can Shen, and Li Rao. "Cardiac echinococcosis secondary to hepatic echinococcosis: a rare case report." Cardiovascular Diagnosis and Therapy 12, no. 1 (February 2022): 147–52. http://dx.doi.org/10.21037/cdt-21-569.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Wu, Lizhong, Pema, Longlong Mu, Mingjue Si, Jie Xu, Guojie Ciren, and Lingling Cai. "Application of Multi-Slice Computed Tomography for the Preoperative Diagnosis and Classification of Pulmonary Cystic Echinococcosis." Pathogens 10, no. 3 (March 16, 2021): 353. http://dx.doi.org/10.3390/pathogens10030353.

Full text

Abstract:

Pulmonary cystic echinococcosis remains a serious threat to public health. A standardized, imaging-based classification method for pulmonary echinococcosis has not yet been developed despite the existence of a standardized ultrasound classification method and treatment plan for hepatic cystic echinococcosis. Chest computed tomography (CT) images from 34 cases of pulmonary cystic echinococcosis with 46 lesions were used for classification based on the World Health Organization (WHO) standardized ultrasound classification of hepatic cystic echinococcosis. CT findings were compared with intraoperative observations and postoperative pathological results to assess accuracy. Pulmonary cystic echinococcosis was common in women (14/34, 41.2%) and children (14/34, 41.2%) with a single cyst (28/46, 60.9%). Most lesions were classified as cystic echinococcosis 1(CE1, 19/46) or cystic echinococcosis 3(CE3, 21/46). Blood leukocytosis was mostly observed in CE3 lesions (100%, 9/9) (p < 0.05). The preoperative CT diagnosis of pulmonary cystic echinococcosis had an accuracy rate of 100%. The preoperative CT typing, and postoperative pathological typing had a coincidence rate of 97.8% (45/46). Our study provided a classification method based on CT imaging for pulmonary cystic echinococcosis that can be used during pre-surgical planning to reduce patient’s postoperative complications and mortality.

APA, Harvard, Vancouver, ISO, and other styles

17

Yapici, O., S. M. Erturk, M. Ulusay, A. Ozel, A. Halefoglu, Z. Karpat, and M. Basak. "Hepatic alveolar echinococcosis: a diagnostic challenge." Journal of the Belgian Society of Radiology 94, no. 1 (January 6, 2011): 21. http://dx.doi.org/10.5334/jbr-btr.479.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Nunnari, Giuseppe. "Hepatic echinococcosis: Clinical and therapeutic aspects." World Journal of Gastroenterology 18, no. 13 (2012): 1448. http://dx.doi.org/10.3748/wjg.v18.i13.1448.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Harman, M., H. Arslan, C. Kotan, O. Etlik, M. Kayan, and A. Deveci. "MRI findings of hepatic alveolar echinococcosis." Clinical Imaging 27, no. 6 (November 2003): 411–16. http://dx.doi.org/10.1016/s0899-7071(03)00006-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Hilmioglu, Fatih, Remzi Dalay, Mehmet Emin Caner, Sedat Boyacioglu, Turhan Cumhur, and Burhan Sahin. "ERCP findings in hepatic alveolar echinococcosis." Gastrointestinal Endoscopy 37, no. 4 (July 1991): 470–72. http://dx.doi.org/10.1016/s0016-5107(91)70783-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Pallua, Kathrin, Guenther Putz, Gottfried Mitterschiffthaler, Christoph Brezinka, Matthias Biebl, and Peter Paal. "Management of hepatic echinococcosis in pregnancy." International Journal of Gynecology & Obstetrics 109, no. 2 (February 21, 2010): 162. http://dx.doi.org/10.1016/j.ijgo.2010.01.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Smego, Raymond A., and Peter Sebanego. "Treatment options for hepatic cystic echinococcosis." International Journal of Infectious Diseases 9, no. 2 (March 2005): 69–76. http://dx.doi.org/10.1016/j.ijid.2004.08.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Korkut, E., G. Ozturk, N. Aksungur, B. Aydinli, U. Memis, and M. Fakirullahoglu. "Multivisceral resection for Hepatic Alveolar Echinococcosis." HPB 21 (2019): S621. http://dx.doi.org/10.1016/j.hpb.2019.10.322.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Korkut, E., G. Ozturk, N. Aksungur, B. Aydinli, U. Memis, and M. Fakirullahoglu. "Multivisceral resection for Hepatic Alveolar Echinococcosis." HPB 21 (2019): S852. http://dx.doi.org/10.1016/j.hpb.2019.10.909.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Wang, Tao, Xianwei Yang, and Wentao Wang. "Another case of hepatic alveolar echinococcosis?" Asian Journal of Surgery 43, no. 11 (November 2020): 1119–20. http://dx.doi.org/10.1016/j.asjsur.2020.08.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

POLAT, K., B. AYDINLI, S. ATAMANALP, M. YILDIRGAN, M. BASOGLU, and G. OZTURK. "Hepatic alveolar echinococcosis: Single center experience." Journal of Gastrointestinal Surgery 9, no. 4 (April 1, 2005): 572. http://dx.doi.org/10.1016/j.gassur.2005.01.143.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Ivanov, S. A., M. V. Kenarskaya, and K. A. Panfilov. "LIVER HYDATIDOSIS: OPTIMIZATION OF SURGICAL TREATMENT METHODS." Science and Innovations in Medicine 3, no. 4 (December 15, 2018): 20–26. http://dx.doi.org/10.35693/2500-1388-2018-0-4-20-26.

Full text

Abstract:

Objectives - optimization of hepatic echinococcosis treatment schemes based on the data analysis of the immediate and long-term results. Material and methods. The study included 373 clinical cases of patients with liver echinococcosis who received treatment in 2005-2018 in Samara Regional Clinical Hospital n. a. V.D. Seredavin. 342 patients underwent a traditional operation, the surgical puncture was performed in 31 patient. Starting from 2003 all patients received the antirelapse chemotherapy with albendazole according to the WHO's recommendations in the postoperative period. Results. The treatment tactics in patients with liver hydatidosis was defined according to the parasite's developmental stage, its localization, and the size of liver cyst. The traditional surgery was successful after one operation in more than 93% of cases, postoperative mortality was 1.46%, the number of postoperative complications - 12.5%, the number of relapses in 5 year follow-up period was 6.8%. In 31 patients we used the puncture surgery treatment of hepatic echinococcosis PAIR and PEVAC-methods. Conclusion. Modern approach to hepatic echinococcosis treatment should provide differentiated

APA, Harvard, Vancouver, ISO, and other styles

28

Akbulut, Sami, and Tevfik Tolga Sahin. "Comment on surgical approaches for definitive treatment of hepatic alveolar echinococcosis: results of a survey in 178 patients." Parasitology 147, no. 13 (August 3, 2020): 1408–10. http://dx.doi.org/10.1017/s0031182020001390.

Full text

Abstract:

AbstractEchinococcus multilocularis causes alveolar echinococcosis which is a chronic, progressive zoonotic disease that mainly affects the liver. Hepatic alveolar echinococcosis is insidious and the patients are asymptomatic most of the time. Generally, it is incidentally found on imaging studies performed for other reasons. Specific symptoms may evolve if the vascular and biliary structures of the liver are affected. Hepatic alveolar echinococcosis shows a similar pattern to malignancies in terms of radiologic and clinical features. For this reason, oncological surgical principles should be applied during the resection of hepatic alveolar echinococcosis. The gold standard surgical treatment is resection with negative surgical margin. However, in patients whose radical resection is not possible other therapeutic options include palliative resection which has no benefit to the patient, and other curative major surgical options such as ex vivo liver resection, and autotransplantation and ultimately liver transplantation. The remnant liver volume has paramount importance if resection is going to be performed. For this reason, occasionally, remnant liver volume hypertrophy is induced by employing either two-stage hepatectomy or associating liver partition and portal vein ligation for staged hepatectomy.

APA, Harvard, Vancouver, ISO, and other styles

29

Chodnicka, Diana, Joanna Giebułtowicz, Lidia Chomicz, and Piotr Wroczyński. "Evaluation of S-transferase and glutathione peroxidase activity as well as the antioxidant capacity value in patients with cystic echinococcosis." Diagnostyka Laboratoryjna 51, no. 1 (April 13, 2015): 31–36. http://dx.doi.org/10.5604/01.3001.0004.1307.

Full text

Abstract:

Introduction: Echinococcosis is a zoonotic disease, increasingly frequent in Poland. Proper treatment of echinococcosis requires the differentiation between a hydatid cyst and a tumor. Mistakes in diagnosis and breaching of the cysts can be potentially fatal. Thus, specific markers are sought for distinguishing tumors from hydatid cysts. Some investigators have focused on differences in the level of oxidative stress markers and the associated differences in the activity of antioxidant enzymes in patients with tumors and in healthy subjects. However, oxidative stress accompanies not only tumors but also echinococcosis. Aim: The aim of the present study was to compare the activity of glutathione peroxidase, glutathione S-transferase, and the antioxidant capacity in plasma of healthy subjects and of patients with unilocular echinococcosis (hepatic localization of the larval form). Moreover, the question was addressed whether antioxidant capacity and activities of glutathione peroxidase and glutathione S-transferase differentiate tumor-bearing individuals from those suffering from echinococcosis. Materials and methods: Plasma collected in ethylenediaminetetraacetic acid was used.Glutathione peroxidase and glutathione S-transferase activities were determined spectrophotometrically, whereas antioxidant capacity was measured using a spectrofluorimetric method. Results and conclusion: It was shown that the antioxidant capacity value and the activity of glutathione S-transferase was significantly higher in the plasma of patients with cystic echinococcosis as compared with healthy subjects. The most promising marker for differentiating hepatic tumors from echinococcosis was the activity of glutathione peroxidase.

APA, Harvard, Vancouver, ISO, and other styles

30

Gasimova, K. F. "Malabsorption syndrome and changes in concentration of endogenous antimicrobial peptids and cytokines in hepatic echinococcosis." Klinicheskaia khirurgiia 87, no. 11-12 (December 28, 2020): 34–39. http://dx.doi.org/10.26779/2522-1396.2020.11-12.34.

Full text

Abstract:

Objective. To study the levels of some cytokines (IL-6, TNF-α) and endogenous antimicrobial peptides (zonulin, calprotectin and lactoferrin) in patients, suffering hepatic echinococcosis, and to follow-up their changes in dynamics of postoperative treatment. Materials and methods. There were examined 29 patients, ageing 35 - 65 yrs old, operated for hepatic echinococcosis. In accordance to scheme of the treatment conducted after laparoscopic echinococcectomy the patients were distributed into two Groups: the first one - 13 patients, who obtained the standard treatment, and the second - 16 patients, to whom, besides the standard treatment, preparation for immunocorrection was prescribed. Antibodies towards the echinococcus IgG, concentration of endogenous antimicrobal peptides and cytokines in the blood serum were studied, using immuno-enzymal analysis in dynamics. Results. There was established, that in preoperative period in patients, suffering hepatic echinococcosis, high levels of the studied inflammation mediators are revealed, comparing with the indices in healthy persons. Conduction of postoperative treatment promotes a staged lowering of the antimicrobal peptides and cytokines concentrations. Standard treatment is less effective in lowering of the inflammation mediators levels, than combination of conventional treatment with immunocorrection. Conclusion. In the patients, suffering hepatic echinococcosis, the levels of cytokines and antimicrobal peptides are raised. Combined treatment with immunocorrection after echinococcusectomy leads to significant lowering of the inflammation mediators levels.

APA, Harvard, Vancouver, ISO, and other styles

31

Novruzbekov, M. S., O. D. Olisov, V. A. Guliaev, K. N. Lutsyk, and K. M. Magomedov. "Transplantation and autotransplantation of the liver in radical treatment of unresectable liver tumors and parasitic diseases." Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 25, no. 4 (December 17, 2020): 49–59. http://dx.doi.org/10.16931/1995-5464.2020449-59.

Full text

Abstract:

Aim. To evaluate results of liver transplantation and ex situ liver resection and autotransplantation in patients with unresectable parasitic and tumor liver lesions. Matherial and methods. A total of 22 orthotopic liver transplants and 4 ex situ liver resection and autotransplantations were performed. Liver transplants performed in 10 cases of unresectable hepatocellular carcinoma, 8 cases of alveolar echinococcosis, 4 cases of hepatic epithelioid haemangioendothelioma. Ex situ liver resection and autotransplantation were performed in 3 cases of alveolar echinococcosis and in 1 case of cholangiocarcinoma. Results. Postoperative complication developed in 38,4% patients. Mortality rate was 19.2%. Patients with alveolar echinococcosis were most complicated group with 36,3% early mortality rate. Mortality in hepatocellular carcinoma group was 10%. There were no early mortality in haemangioendothelioma and cholangiocarcinoma patients. Median overall survival for hepatocelluler carcinoma, alveolar echinococcosis and hepatic epithelioid haemangioendothelioma groups was 48, 36, 20 months respectively. Patient after ex situ liver resection for cholangiocarcinoma alive for 24 months and still disease free. Conclusion. Liver transplantation and ex situ liver resection and autotransplantation is the only opportunity for radical treatment for unresectable alveolar echinococcosis and some oncological diseases of the organ. Patients with unresectable alveolar echinococcosis is a high risk group of postoperative complications due to initial poor physical status, long-time disease, chronically infections and parasitic invasion.

APA, Harvard, Vancouver, ISO, and other styles

32

Ma, Yuan, Congmin Chen, Xinyun Ding, Xiaohui Zhang, and Yuqing Ma. "Hepatic cystic echinococcosis misdiagnosed as hepatic hamartoma: A case report." Asian Journal of Surgery 45, no. 4 (April 2022): 1086–87. http://dx.doi.org/10.1016/j.asjsur.2022.01.071.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Ito, A., and C. M. Budke. "The present situation of echinococcoses in Mongolia." Journal of Helminthology 89, no. 6 (August 3, 2015): 680–88. http://dx.doi.org/10.1017/s0022149x15000620.

Full text

Abstract:

AbstractThis review presents the historical and current situation of echinococcoses in Mongolia. Since the collapse of the Soviet Union in 1991, Mongolia's health surveillance infrastructure has been very poor, especially as it pertains to chronic diseases, including neglected zoonotic diseases (NZDs). Although there is anecdotal evidence of people dying from hepatic disease due to infection with the larval stage of Echinococcus spp., there are very few published reports. All confirmed cases of echinococcoses in Mongolia are from hospitals located in the capital city of Ulaanbaatar. Cases of cystic echinococcosis (CE), caused by either Echinococcus granulosus sensu stricto or Echinococcus canadensis are believed to be relatively common throughout Mongolia. In contrast, cases of alveolar echinococcosis (AE), caused by Echinococcus multilocularis, are believed to be rare. Recent wild-animal surveys have revealed that wolves (Canis lupus) are the major definitive hosts of E. canadensis, whereas both wolves and red foxes (Vulpes vulpes) are the primary definitive hosts of E. multilocularis. Although wild-animal surveys have begun to elucidate the transmission of Echinococcus spp. in Mongolia, there have yet to be large-scale studies conducted in domestic dogs and livestock. Therefore, further epidemiological studies, in addition to education-based control campaigns, are needed to help combat this NZD.

APA, Harvard, Vancouver, ISO, and other styles

34

Ma, Li, De-Cai Chen, Shi-Yue Zou, Yan-Yi Liu, Lin-Yong Zhou, and Zhi-Gang Xiu. "Epidemiological characteristics of hepatic echinococcosis, concurrent cerebral echinococcosis, and pulmonary echinococcosis in Ganzi County, Sichuan Province, China." Medicine 99, no. 15 (April 2020): e19753. http://dx.doi.org/10.1097/md.0000000000019753.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Kasirga, Hasan Erhun, and Yeliz Cagan Appak. "Hepatic Cystic Echinococcosis: Report of Two Cases." Turkish Journal of Parasitology 37, no. 4 (January 12, 2014): 285–87. http://dx.doi.org/10.5152/tpd.2013.3042.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Van Steenbergen, W., J. Fevery, L. Broeckaert, E. Ponette, G. Marchal, A. Baert, F. Penninckx, R. Kerremans, and J. De Groote. "Hepatic echinococcosis ruptured into the biliary tract." Journal of Hepatology 4, no. 1 (January 1987): 133–39. http://dx.doi.org/10.1016/s0168-8278(87)80020-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Bedioui, Heykal, Kais Nouira, Sofiene Ayadi, Amine Daghfous, Malek Bakhtri, Rachid Ksantini, Faouzi Chebbi, et al. "Budd-Chiari syndrome secondary to hepatic echinococcosis." Gastroentérologie Clinique et Biologique 31, no. 8-9 (September 2007): 721–24. http://dx.doi.org/10.1016/s0399-8320(07)91933-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Ozturk, Gurkan, Kamil Yalcin Polat, Mehmet Ilhan Yildirgan, Bulent Aydinli, Sabri Selcuk Atamanalp, and Unal Aydin. "Endoscopic retrograde cholangiopancreatography in hepatic alveolar echinococcosis." Journal of Gastroenterology and Hepatology 24, no. 8 (August 2009): 1365–69. http://dx.doi.org/10.1111/j.1440-1746.2009.05877.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Qu, B., Y. Lv, X. W. Ji, B. Han, C. Liu, and L. Yu. "488 MANAGEMENT OF ADVANCED HEPATIC ALVEOLAR ECHINOCOCCOSIS." Journal of Hepatology 50 (April 2009): S183. http://dx.doi.org/10.1016/s0168-8278(09)60490-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Watanabe, Naoto, Hikaru Seto, Tetsuya Kamei, Ryusuke Futatsuya, Masashi Shimizu, Masanari Kageyama, and Masao Kakishita. "Colloid liver SPECT of hepatic alveolar echinococcosis." Annals of Nuclear Medicine 7, no. 4 (December 1993): 277–79. http://dx.doi.org/10.1007/bf03164711.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Ozturk, G., E. Korkut, N. Aksungur, and B. Aydinli. "Hepatic alveolar echinococcosis-sixteen years 237 cases." HPB 21 (2019): S590. http://dx.doi.org/10.1016/j.hpb.2019.10.226.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Salm, L. A., A. Lachenmayer, S. F. Perrodin, D. Candinas, and G. Beldi. "Surgical treatment strategies for hepatic alveolar echinococcosis." Food and Waterborne Parasitology 15 (June 2019): e00050. http://dx.doi.org/10.1016/j.fawpar.2019.e00050.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Ohnishi, Kenji, Fukumi Nakamura-Uchiyama, Nobuhiro Komiya, Shunsuke Satoh, Takao Ohkubo, and Nobutaka Umekita. "Hepatic Cystic Echinococcosis with Specific CT Findings." Internal Medicine 47, no. 8 (2008): 803–5. http://dx.doi.org/10.2169/internalmedicine.47.0773.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Artemyev, A. I., E. V. Naydenov, D. A. Zabezhinsky, K. K. Gubarev, I. Y. Kolyshev, V. S. Rudakov, M. V. Shabalin, V. V. Shcherbin, A. N. Bashkov, and S. E. Voskanyan. "Liver Transplantation for Unresectable Hepatic Alveolar Echinococcosis." Sovremennye tehnologii v medicine 9, no. 1 (March 2017): 123. http://dx.doi.org/10.17691/stm2017.9.1.16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Maghrebi, H., A. El Heni, R. Rhaiem, A. Makni, A. Daghfous, F. Fteriche, M. Jouini, M. Kacem, and Z. Bensafta. "Budd-chiari syndrome secondary to hepatic echinococcosis." HPB 18 (April 2016): e221. http://dx.doi.org/10.1016/j.hpb.2016.02.548.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Qu, Bo, Chang Liu, Yi Yang, Jianhui Li, Chenwang Jin, Bo Wang, Liang Yu, and Yi Lv. "Giant hepatic alveolar echinococcosis in an adult." American Journal of Surgery 198, no. 2 (August 2009): e23-e24. http://dx.doi.org/10.1016/j.amjsurg.2008.12.036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Pitt, Henry A., John Korzellus, and Ronald K. Tompkins. "Management of hepatic echinococcosis in Southern California." American Journal of Surgery 152, no. 1 (July 1986): 110–15. http://dx.doi.org/10.1016/0002-9610(86)90159-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Monakhov, Artem, Stepan Zubenko, Konstantin Semash, Olga Tsiroulnikova, and Sergey Gautier. "Advanced liver surgery for hepatic alveolar echinococcosis." Korean Journal of Transplantation 36, no. 1 (November 17, 2022): S112. http://dx.doi.org/10.4285/atw2022.f-2317.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Al Qassab, Narjis Jalal, Mahmood Alawainati, Safa Al-Khawaja, and Batool Alhejairi. "Clinical Characteristics and Management of Patients with Cystic Echinococcosis in Salmaniya Medical Complex – A Retrospective Descriptive Study." Journal of the Bahrain Medical Society 34, no. 1 (2022): 42–49. http://dx.doi.org/10.26715/jbms.34_2022_1_6.

Full text

Abstract:

Introduction: Cystic Echinococcosis, commonly known as hydatid cyst disease, is a zoonotic disease caused by Echinococcus granulosus and commonly affects hepatic and pulmonary tissues. Although it is prevalent in some countries in the middle east, no epidemiological studies have been conducted to determine the epidemiology of cystic echinococcosis in the Kingdom of Bahrain. Methods: This is a retrospective descriptive study of all cystic echinococcosis cases diagnosed in Salmaniya medical complex between 2015 and 2020. Descriptive analysis of clinical, radiological, and histological data using frequencies and percentages was conducted. Results: A total of 11 patients were identified with cystic echinococcosis. Most of them (n=9; 81.82%) reported a travel history to endemic areas and had liver involvement. While most laboratory data were within normal ranges, radiological investigations of hepatic lesions revealed characteristic features of hydatid cysts, including well-defined margins (n=9, 100%), hypoechoic liver cysts (n=9, 100%) and floating lily sign (n=5, 55.56%). All pulmonary (n=6, 100%) and most hepatic cysts (n=7, 77.78%) required surgical interventions. Reoperation rates were 33.33% (n=3) and 16.67% (n=1) for hepatic and pulmonary cysts, respectively. Conclusion: Hydatid cyst is a rare disease in Bahrain and is seen mainly in patients who travel to endemic areas. Thus, extracting a detailed travel history is essential for the diagnosis of this disease. Clinical presentations are variable due to different tissues involved, natural history of the disease, and patients’ characteristics. Although prolonged medical treatment and minimally invasive procedures are of value, surgical interventions are required in most cases. Keywords: Bahrain, Cysts, Echinococcus granulosus, Humans, Zoonoses

APA, Harvard, Vancouver, ISO, and other styles

50

Liu, Chuanchuan, Haining Fan, and Ri-li Ge. "A Case of Human Hepatic Alveolar Echinococcosis Accompanied by Lung and Brain Metastases." Korean Journal of Parasitology 59, no. 3 (June 21, 2021): 291–96. http://dx.doi.org/10.3347/kjp.2021.59.3.291.

Full text

Abstract:

Alveolar echinococcosis (AE) is considered as a fatal zoonosis caused by the larvae of Echinococcus multilocularis. The lungs and brain are the most common metastatic organs. We report a human case of hepatic alveolar echinococcosis accompanied by lung and brain metastasis. In particular, the patient had a history of tuberculosis and the lung lesions were easily misdiagnosed as lung abscesses. The lesions of liver and lung underwent radical resection and confirmed as alveolar echinococcosis by pathological examination. The patient had no surgical complications after operation and was discharged after symptomatic treatment. Unfortunately, the patient later developed multiple intracerebral AE metastases. We required the patient to take albendazole orally for life and follow up.

APA, Harvard, Vancouver, ISO, and other styles

Journal articles on the topic 'Hepatic Echinococcosis'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles